Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) advanced 16.62% amid news that the company was commencing a non-deal investor roadshow in the United States with Credit Suisse. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), stock opened at $9.83 in last session, and closed at $9.96, while the day range of PRAN stock is $9.01 – $10.25. The stock showed a positive weekly performance of 20.29%.
Adamis Pharmaceuticals Corp (NASDAQ:ADMP), has announced an important addition to its intellectual property with receipt of a notice of allowance of patent claims supporting its cancer immunotherapy portfolio in the US. Adamis Pharmaceuticals Corp (NASDAQ:ADMP), stock opened at $7.10, in last session and closed at $6.81, by gaining 1.95%. The 52 week range of ADMP is $0.44 – $17.17. Company’s market capitalization is $67.50million.
Eric Steen, Chief Executive Officer of InfuSystem Holdings Inc (NYSEMKT:INFU), noted that electronic connectivity with customers is a key element of the InfuSystem Holdings Inc (NYSEMKT:INFU), growth strategy. “We are thrilled to see our efforts drive the kinds of efficiencies we anticipated with AMS. We have built a scalable, rapid-deployment model and we are committed to driving this type of cutting edge integration to the entire oncology community. We look forward to rolling out implementations with additional customers on EMR platforms in 2014.” InfuSystem Holdings Inc (NYSEMKT:INFU), stock advanced 1.20% and finished the last session at $2.53. The EPS of the stock remained 0.04. Company’s market capitalization is $55.88million.
Imprimis Pharmaceuticals Inc (NASDAQ:IMMY) rallied Tuesday, trading more than 8% higher in late trade after the drug-maker said it will exhibit its pre-commercial ophthalmic formulations at an upcoming industry conference starting later this week. Imprimis Pharmaceuticals Inc (NASDAQ:IMMY), stock opened the session at $8.01, and closed the session at $8.22. The 52 week range of the IMMY stock remained $3.01 – $10.00 and the day range was $7.95 – $9.30.